M. Pandolfino

发表

PD‐L1 expression by tumor cell lines: A predictive marker in melanoma

B. Dréno, M. Denis, A. Khammari, 2018, Experimental Dermatology.

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

B. Dréno, Y. Godet, V. Vignard, 2007, Cancer Immunology, Immunotherapy.

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

B. Dréno, A. Khammari, F. Jotereau, 2002, Cancer Immunology, Immunotherapy.

Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

B. Dréno, S. Billaudel, A. Khammari, 2002, Cancer Immunology, Immunotherapy.

TFrequencies of Additional MelanA-Specific Patients Is Followed by Increased MelanA-Specific CTL Clones in Melanoma Adoptive Transfer of Tumor-Reactive Jotereau and

K. Echasserieau, B. Dréno, A. Lim, 2005 .

Tissue Biomarkers in Melanoma Patients Treated with TIL

B. Dréno, A. Khammari, G. Quéreux, 2012, PloS one.

Absence of amplification of CD4+CD25high regulatory T cells during in vitro expansion of tumor‐infiltrating lymphocytes in melanoma patients

C. Volteau, A. Khammari, F. Lemaı̂tre, 2008, Experimental dermatology.

Comprehensive analysis of the frequency of recognition of melanoma‐associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

M. Bonneville, F. Jotereau, N. Labarrière, 2001, European journal of immunology.

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

C. Volteau, B. Dréno, A. Khammari, 2007, Cancer Immunology, Immunotherapy.

Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy1

F. Jotereau, E. Diéz, N. Gervois, 2002, The Journal of Immunology.

Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma.

B. Dréno, F. Jotereau, P. Litoux, 1996, European journal of cancer.

Pathogenetic mechanisms of vitiligo in a patient with Sézary syndrome

B. Dréno, A. Khammari, G. Quéreux, 2005, The British journal of dermatology.

High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.

B. Dréno, F. Jotereau, N. Labarrière, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Specificity, T cell receptor diversity and activation requirements of CD4+ and CD8+ clones derived from human melanoma‐infiltrating lymphocytes

C. Viret, F. Jotereau, E. Diéz, 1992, European journal of immunology.

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.

B. Dréno, A. Khammari, A. Knol, 2019, Acta dermato-venereologica.

Defective lymphokine production by most CD8+ and CD4+ tumor‐specific T cell clones derived from human melanoma‐infiltrating lymphocytes in response to autologous tumor cells in vitro

C. Viret, F. Jotereau, E. Diéz, 1994, European journal of immunology.

Comparison of three culture media for the establishment of melanoma cell lines

B. Dréno, A. Knol, M. Pandolfino, 2010, Cytotechnology.

High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.

B. Dréno, J. Douillard, F. Jotereau, 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Defective activations of STAT3 Ser727 and PKC isoforms lead to oncostatin M resistance in metastatic melanoma cells

B. Dréno, F. Blanchard, Y. Jacques, 2009, The Journal of pathology.

Relationship between responsiveness of cancer cells to Oncostatin M and/or IL‐6 and survival of stage III melanoma patients treated with tumour‐infiltrating lymphocytes

B. Dréno, A. Khammari, F. Blanchard, 2008, The Journal of pathology.

Comparative analysis of BRAF, NRAS and c‐KIT mutation status between tumor tissues and autologous tumor cell‐lines of stage III/IV melanoma

B. Dréno, M. Denis, F. Nguyen, 2015, Experimental dermatology.

Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells1

K. Echasserieau, B. Dréno, A. Lim, 2005, The Journal of Immunology.

Adoptive TIL Transfer in the Adjuvant Setting for Melanoma: Long-Term Patient Survival

B. Dréno, M. Denis, A. Khammari, 2014, Journal of immunology research.

Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

B. Dréno, C. Viret, F. Jotereau, 1997, Journal of immunology.

High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement

Francine Jotereau, B. Dréno, F. Jotereau, 2001, Cancer Immunology, Immunotherapy.

Frequency and relative fraction of tumor antigen‐specific T cells among lymphocytes from melanoma‐invaded lymph nodes

B. Dréno, F. Jotereau, N. Labarrière, 1998, International Journal of Cancer.

Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones.

B. Dréno, V. Vignard, A. Khammari, 2009, The Journal of investigative dermatology.

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial

B. Dréno, A. Khammari, N. Labarrière, 2020, Cancer Immunology, Immunotherapy.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients

C. Volteau, B. Dréno, N. Basset-Seguin, 2018, Journal of immunology research.

Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

B. Dréno, J. Limacher, A. Khammari, 2015, Cancer Immunology, Immunotherapy.

Tissue prognostic markers for adoptive immunotherapy in melanoma.

C. Volteau, B. Dréno, A. Khammari, 2007, European journal of dermatology : EJD.

Value of large scale expansion of tumor infiltrating lymphocytes in a compartmentalised gas-permeable bag: interests for adoptive immunotherapy

Bruno Delorme, B. Dréno, J. David, 2011, Journal of Translational Medicine.

CD8(+) T lymphocytes reactive against Epstein-Barr virus antigens in skin lesions of a patient with Sézary syndrome.

B. Dréno, A. Khammari, G. Quéreux, 2005, Journal of the American Academy of Dermatology.

Presence of Epstein-Barr virus in Langerhans cells of CTCL lesions.

B. Dréno, A. Khammari, G. Quéreux, 2005, The Journal of investigative dermatology.

Loss of oncostatin M receptor β in metastatic melanoma cells

B. Dréno, A. Khammari, F. Blanchard, 2007, Oncogene.

Loss of oncostatin M receptor beta in metastatic melanoma cells.

B. Dréno, A. Khammari, F. Blanchard, 2007, Oncogene.